Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Paralon Biotechnology

Request full access

Parylene conformal coating services for multiple industries

ChinaFounded 2012Defence

About Shanghai Paralon Biotechnology

Shanghai Paralon Biotechnology Co., Ltd. is a high-tech enterprise specializing in the application of Parylene and other special coating technologies. Founded in December 2012, the company's core team has over two decades of experience in Parylene material research and application. The founder and CEO is Zhang Jingang. The legal representative is Zhang Yue, who also serves as the chairman.

The company focuses on providing Parylene coating services, which are protective polymer coatings applied through a chemical vapor deposition (CVD) process in a vacuum. This process ensures a uniform, pinhole-free, and thin protective layer that conforms to any shape. Paralon has developed its own production equipment and holds 22 national patents and 10 software copyrights. Their services cater to a wide range of industries, including medical devices, electronics, automotive, aerospace, military, and semiconductor manufacturing. Key clients have included well-known companies like Huawei, ZTE, Philips, and MicroPort.

Paralon's business model encompasses providing comprehensive solutions from technical introductions and sample production to batch processing, sales of coating equipment, and raw materials. The company has secured significant funding to support its growth, including an A-round of over 50 million RMB in February 2023 from investors such as CITIC Construction Investment Capital and Yida Capital. This was followed by a B-round of nearly 100 million RMB in February 2026, led by SDIC Chuanghe. These funds are allocated for purchasing technical equipment, expanding and upgrading production lines, and for continuous research and development.

The firm operates out of clean workshops rated at various levels, including 100,000, 10,000, and static 100-class, and has obtained ISO9001 quality management system certification. Paralon has also developed proprietary composite functional coating technologies to solve issues related to material adhesion and to add properties like antibacterial and wear resistance.

Source: Dealroom company data

At a glance

Status
Operational
Employees
2
Open positions
None listed
Dealroom signal
25.3/100
Industry
Semiconductors
Sector
Defence Applications, Advanced Materials, Semiconductor Materials, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Feb 2026 $14M $55M SDIC Unity Capital · Detong Capital · Addor Capital ↗
SERIES A✓Equity / VC Jan 2023 $7.6M $30M China Securities · Detong Capital · Addor Capital · Su Guofa ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Shanghai Paralon Biotechnology website traffic

Latest recorded traffic for Shanghai Paralon Biotechnology is 5.8K monthly website visits, up 1557.1% over the last three months. Shanghai Paralon Biotechnology's team grew 0% over the past year.

Latest monthly visits5.8K 3-month web change+1557.1% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shanghai Paralon Biotechnology in its local ecosystem

Live from Dealroom

The Shanghai Paralon Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • China Securities
  • Detong Capital
  • Addor Capital
  • Su Guofa
  • SDIC Unity Capital
Employees 2 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Paralon Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Paralon Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.